BNP Paribas Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$279M Sell
2,316,095
-338,405
-13% -$39.1M 0.32% 55
2025
Q4
$279M Buy
2,654,500
+1,676,271
+171% +$157M 0.32% 56
2025
Q3
$81.4M Sell
978,229
-300,308
-23% -$24.7M 0.21% 109
2025
Q2
$101M Buy
1,278,537
+62,436
+5% +$4.96M 0.25% 91
2025
Q1
$109M Sell
1,216,101
-264,908
-18% -$24.7M 0.29% 80
2024
Q4
$147M Buy
1,481,009
+66,220
+5% +$6.83M 0.37% 59
2024
Q3
$161M Sell
1,414,789
-142,958
-9% -$17M 0.4% 48
2024
Q2
$193M Buy
1,557,747
+48,415
+3% +$6.24M 0.5% 33
2024
Q1
$199M Buy
1,509,332
+435,308
+41% +$53.7M 0.53% 37
2023
Q4
$117M Sell
1,074,024
-7,638
-0.7% -$793K 0.33% 70
2023
Q3
$111M Sell
1,081,662
-168,008
-13% -$18.1M 0.34% 67
2023
Q2
$144M Sell
1,249,670
-279,058
-18% -$31.7M 0.45% 47
2023
Q1
$163M Buy
1,528,728
+261,034
+21% +$28.2M 0.56% 33
2022
Q4
$141M Sell
1,267,694
-237,343
-16% -$24.3M 0.5% 38
2022
Q3
$130M Buy
1,505,037
+241,215
+19% +$21.5M 0.51% 35
2022
Q2
$115M Buy
1,263,822
+82,138
+7% +$7.28M 0.44% 46
2022
Q1
$97M Buy
1,181,684
+85,354
+8% +$6.73M 0.34% 62
2021
Q4
$84M Buy
1,096,330
+213,022
+24% +$17M 0.28% 81
2021
Q3
$66.3M Buy
883,308
+136,554
+18% +$10.4M 0.25% 91
2021
Q2
$58.1M Buy
746,754
+24,978
+3% +$1.86M 0.21% 118
2021
Q1
$53.1M Sell
721,776
-201,269
-22% -$14.8M 0.22% 107
2020
Q4
$72M Sell
923,045
-45,406
-5% -$3.47M 0.33% 70
2020
Q3
$76.7M Sell
968,451
-233,165
-19% -$18.3M 0.44% 48
2020
Q2
$88.7M Buy
1,201,616
+97,186
+9% +$7.32M 0.6% 31
2020
Q1
$81.1M Sell
1,104,430
-51,452
-4% -$4.04M 0.69% 20
2019
Q4
$100M Buy
1,155,882
+128,624
+13% +$10.6M 0.69% 18
2019
Q3
$82.5M Sell
1,027,258
-293
-0% -$23.5K 0.64% 22
2019
Q2
$82.2M Buy
1,027,551
+52,988
+5% +$4.06M 0.67% 18
2019
Q1
$77.3M Sell
974,563
-6,974
-0.7% -$522K 0.65% 22
2018
Q4
$70.6M Buy
981,537
+178,128
+22% +$12.6M 0.65% 17
2018
Q3
$54.4M Buy
803,409
+22,068
+3% +$1.41M 0.42% 50
2018
Q2
$45.3M Sell
781,341
-273,675
-26% -$15.4M 0.38% 48
2018
Q1
$54.8M Sell
1,055,016
-560,953
-35% -$30.3M 0.46% 33
2017
Q4
$86.8M Buy
1,615,969
+91,679
+6% +$5.08M 0.74% 15
2017
Q3
$93.1M Sell
1,524,290
-77,070
-5% -$4.67M 0.79% 15
2017
Q2
$97.9M Buy
1,601,360
+24,232
+2% +$1.48M 0.87% 13
2017
Q1
$95.6M Sell
1,577,128
-15,342
-1% -$931K 0.88% 12
2016
Q4
$89.5M Sell
1,592,470
-29,655
-2% -$1.74M 0.86% 12
2016
Q3
$96.6M Sell
1,622,125
-78,959
-5% -$4.62M 0.82% 10
2016
Q2
$93.5M Sell
1,701,084
-710,922
-29% -$37.8M 0.79% 12
2016
Q1
$122M Buy
2,412,006
+349,501
+17% +$17.1M 1.03% 8
2015
Q4
$104M Buy
2,062,505
+693,411
+51% +$35M 0.88% 8
2015
Q3
$64.5M Sell
1,369,094
-481,587
-26% -$25.6M 0.57% 28
2015
Q2
$101M Sell
1,850,681
-175,230
-9% -$9.83M 0.81% 9
2015
Q1
$111M Buy
2,025,911
+343,234
+20% +$19.4M 0.85% 8
2014
Q4
$91.2M Sell
1,682,677
-1,066,157
-39% -$59.4M 0.74% 15
2014
Q3
$155M Buy
2,748,834
+406,513
+17% +$22.8M 1.26% 5
2014
Q2
$129M Buy
2,342,321
+974,410
+71% +$53.2M 1% 10
2014
Q1
$74.1M Buy
1,367,911
+285,089
+26% +$14.8M 0.56% 32
2013
Q4
$51.7M Sell
1,082,822
-110,709
-9% -$5.06M 0.39% 75
2013
Q3
$54.2M Sell
1,193,531
-325,102
-21% -$14.8M 0.41% 70
2013
Q2
$67.3M Buy
+1,518,633
New +$67.8M 0.5% 51

Other funds holding MRK

BNP Paribas Asset Management's MRK Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its Merck (MRK) stake by 13% in Q1 2026, selling an estimated $39.1M and leaving 2,316,095 shares worth $279M. The position accounts for 0.32% of the portfolio, ranked #55.

BNP Paribas Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $279M in Q4 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • BNP Paribas Asset Management held 2,316,095 shares of Merck worth $279M as of Q1 2026.
  • BNP Paribas Asset Management sold 338,405 Merck shares in Q1 2026, an estimated $39.1M.
  • Merck made up 0.32% of BNP Paribas Asset Management's portfolio in Q1 2026, its #55 holding.
  • BNP Paribas Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Asset Management's Merck position peaked at $279M in Q4 2025.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.